These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 9150830)
21. Further evidence of a dose-response threshold for haloperidol in psychosis. Stone CK; Garve DL; Griffith J; Hirschowitz J; Bennett J Am J Psychiatry; 1995 Aug; 152(8):1210-2. PubMed ID: 7625474 [TBL] [Abstract][Full Text] [Related]
22. Parenteral haloperidol for rapid control of severe, disruptive symptoms of acute schizophrenia. Reschke RW Dis Nerv Syst; 1974 Mar; 35(3):112-5. PubMed ID: 17894080 [TBL] [Abstract][Full Text] [Related]
23. Multiple fixed doses of "Seroquel" (quetiapine) in patients with acute exacerbation of schizophrenia: a comparison with haloperidol and placebo. The Seroquel Trial 13 Study Group. Arvanitis LA; Miller BG Biol Psychiatry; 1997 Aug; 42(4):233-46. PubMed ID: 9270900 [TBL] [Abstract][Full Text] [Related]
24. A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation. Chouinard G; Safadi G; Beauclair L J Clin Psychopharmacol; 1994 Dec; 14(6):377-84. PubMed ID: 7884017 [TBL] [Abstract][Full Text] [Related]
25. Clonidine plus haloperidol in the treatment of schizophrenia/psychosis. Maas JW; Miller AL; Tekell JL; Funderburg L; Silva JA; True J; Velligan D; Berman N; Bowden CL J Clin Psychopharmacol; 1995 Oct; 15(5):361-4. PubMed ID: 8830068 [TBL] [Abstract][Full Text] [Related]
26. Prediction of haloperidol steady-state levels in plasma after a single test dose. Javaid JI; Janicak PG; Sharma RP; Leach AM; Davis JM; Wang Z J Clin Psychopharmacol; 1996 Feb; 16(1):45-50. PubMed ID: 8834418 [TBL] [Abstract][Full Text] [Related]
27. Rapid tranquilization of severely agitated patients with schizophrenia spectrum disorders: a naturalistic, rater-blinded, randomized, controlled study with oral haloperidol, risperidone, and olanzapine. Walther S; Moggi F; Horn H; Moskvitin K; Abderhalden C; Maier N; Strik W; Müller TJ J Clin Psychopharmacol; 2014 Feb; 34(1):124-8. PubMed ID: 24346752 [TBL] [Abstract][Full Text] [Related]
28. Determining the optimal dose of haloperidol in first-episode psychosis. Oosthuizen P; Emsley RA; Turner J; Keyter N J Psychopharmacol; 2001 Dec; 15(4):251-5. PubMed ID: 11769818 [TBL] [Abstract][Full Text] [Related]
29. Haloperidol: therapeutic window in schizophrenia. Palao DJ; Arauxo A; Brunet M; Bernardo M; Haro JM; Ferrer J; Gonzalez-Monclus E J Clin Psychopharmacol; 1994 Oct; 14(5):303-10. PubMed ID: 7806684 [TBL] [Abstract][Full Text] [Related]
30. Risperidone in the treatment of patients with chronic schizophrenia: a multi-national, multi-centre, double-blind, parallel-group study versus haloperidol. Risperidone Study Group. Peuskens J Br J Psychiatry; 1995 Jun; 166(6):712-26; discussion 727-33. PubMed ID: 7545060 [TBL] [Abstract][Full Text] [Related]
31. Neuroleptic monitoring: relation between antipsychotic efficiency and radioreceptor assay of serum haloperidol. Odou P; Vaiva G; Luyckx M; Brunet C; Dine T; Gressier B; Cazin M; Cazin JC Eur J Clin Pharmacol; 1996; 50(5):357-63. PubMed ID: 8839656 [TBL] [Abstract][Full Text] [Related]
33. Coadministration of fluvoxamine increases serum concentrations of haloperidol. Daniel DG; Randolph C; Jaskiw G; Handel S; Williams T; Abi-Dargham A; Shoaf S; Egan M; Elkashef A; Liboff S J Clin Psychopharmacol; 1994 Oct; 14(5):340-3. PubMed ID: 7806690 [TBL] [Abstract][Full Text] [Related]
34. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [TBL] [Abstract][Full Text] [Related]
35. A randomized, controlled comparison of the efficacy and tolerability of low and high doses of haloperidol in the treatment of first-episode psychosis. Oosthuizen P; Emsley R; Jadri Turner H; Keyter N Int J Neuropsychopharmacol; 2004 Jun; 7(2):125-31. PubMed ID: 15003147 [TBL] [Abstract][Full Text] [Related]
37. A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients. Chouinard G; Jones B; Remington G; Bloom D; Addington D; MacEwan GW; Labelle A; Beauclair L; Arnott W J Clin Psychopharmacol; 1993 Feb; 13(1):25-40. PubMed ID: 7683702 [TBL] [Abstract][Full Text] [Related]
38. Double blind comparative study of remoxipride and haloperidol in acute schizophrenic patients. Den Boer JA; Ravelli DP; Huisman J; Ohrvik J; Verhoeven WM; Westenberg HG Psychopharmacology (Berl); 1990; 102(1):76-84. PubMed ID: 1975448 [TBL] [Abstract][Full Text] [Related]
39. Haloperidol plasma levels and acute clinical change in schizophrenia. Coryell W; Kelly M; Perry PJ; Miller DD J Clin Psychopharmacol; 1990 Dec; 10(6):397-402. PubMed ID: 2286709 [TBL] [Abstract][Full Text] [Related]